CN103798771A - 一种含有中药提取物的复方制剂 - Google Patents
一种含有中药提取物的复方制剂 Download PDFInfo
- Publication number
- CN103798771A CN103798771A CN201210449016.1A CN201210449016A CN103798771A CN 103798771 A CN103798771 A CN 103798771A CN 201210449016 A CN201210449016 A CN 201210449016A CN 103798771 A CN103798771 A CN 103798771A
- Authority
- CN
- China
- Prior art keywords
- compound preparation
- extract
- traditional chinese
- american ginseng
- astragalus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 15
- 150000001875 compounds Chemical class 0.000 title claims abstract description 9
- 239000003814 drug Substances 0.000 title abstract description 6
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 12
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 10
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims abstract description 8
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 8
- 239000004225 ferrous lactate Substances 0.000 claims abstract description 8
- 229940037907 ferrous lactate Drugs 0.000 claims abstract description 8
- 235000013925 ferrous lactate Nutrition 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 7
- 241001061264 Astragalus Species 0.000 claims abstract description 6
- 235000006533 astragalus Nutrition 0.000 claims abstract description 6
- 210000004233 talus Anatomy 0.000 claims abstract description 6
- 229940107666 astragalus root Drugs 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 2
- 229930182490 saponin Natural products 0.000 claims description 2
- 150000007949 saponins Chemical class 0.000 claims description 2
- -1 terpene lactone Chemical class 0.000 claims description 2
- 235000007586 terpenes Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 4
- 239000009429 Ginkgo biloba extract Substances 0.000 abstract description 2
- 229940068052 ginkgo biloba extract Drugs 0.000 abstract description 2
- 235000020686 ginkgo biloba extract Nutrition 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000019206 astragalus extract Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000009636 Huang Qi Substances 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 241000218628 Ginkgo Species 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000000496 anti-anoxic effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 208000001286 intracranial vasospasm Diseases 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种含有中药提取物的复方制剂，组成该制剂的活性成分及其重量含量是：银杏叶提取物30-45％、西洋参提取物30-40％、黄芪提取物15-28％、乳酸亚铁2-10％，余为辅料。本发明将银杏叶、西洋参、黄芪等传统中药材与乳酸亚铁科学配伍，具有明显提高抗疲劳的效果，无明显副作用。
Description
技术领域
本发明涉及保健食品技术领域，具体涉及的是一种用于缓解体力疲劳的含有中药提取物的复方制剂。
背景技术
现代医学认为疲劳是机体超限而引起的功能降低并出现机体不适的状态，主要表现为疲劳困倦，可出现头晕、健忘、睡眠质量下降等伴随症状。疲劳的产生与能源物质消耗、代谢产物堆积、内环境稳定性失调、自由基影响等因素关系密切。随着人们保健意以的加强，各种抗疲劳产品应运而生，其中中药类产品以其天然、安全、无毒副作用等优势，日益受到人们的关注，如虫草胶囊、西洋参片等。因此，开发具有中医特色的缓解体力疲劳的保健食品，不仅可以弥补现代医学在治疗上的不足，发挥中医中药的优势，而且其适宜人群范围广，市场需求大，具有广阔的市场前景。
发明内容
本发明的目的就是提供一种用于缓解体力疲劳的含有中药提取物的复方制剂。不仅辨证组方，从根本上解决疲劳之根源，还结合了营养素、强化剂等能量物质，以促进体力恢复。
为了实现本发明目的，组成该保健食品的活性成分及其重量含量是：银杏叶提取物30-45％、西洋参提取物30-40％、黄芪提取物15-28％、乳酸亚铁2-10％，余为辅料。
本发明中银杏叶提取物含萜类内酯不少于5％；西洋参提取物总皂苷含量不少于5％；黄芪提取物含黄芪多糖不少于20％。
与现有技术相比，本发明的优点是：辨证组方并结合营养素，疗效明确。
银杏叶：为银杏树的叶，主要成分为银杏黄酮。性味苦、涩，平。功能敛肺平喘，活血止痛。用于肺虚咳喘，以及高血脂、高血压、冠心病心绞痛、脑血管痉挛等。煎服5～10g，或制成片剂、注射剂。
西洋参：为五加科植物西洋参Panax quinquefolium L.的根。主产于美国、加拿大。我国北京、吉林、辽宁等地亦有栽培。秋季采挖生长3～6年的根，切片生用。西洋参有抗休克作用，能明显提高失血性休克大鼠存活率；对大脑有镇静作用，对生命中枢则有中度兴奋作用；还具抗缺氧、抗心肌缺血、抗心肌氧化、增加心肌收缩力、抗心律失常、抗疲劳、抗应激、抗惊厥、降血糖、止血和抗利尿作用。
黄芪：为豆科植物蒙古黄芪Astragalus memeranaceus(Fisch.)Bge.var.mongholicus(Bge.)Hsiao或膜荚黄芪A.membranaceus(Fisch.)Bge.的根。主产于内蒙古、山西、黑龙江等地。春秋二季采挖，除去须根及根头，晒干，切片，生用或蜜炙用。黄芪能促进机体代谢、抗疲劳、促进血清和肝脏蛋白质的更新；有明显的利尿作用，能消除实验性肾炎尿蛋白；能改善贫血动物现象；能升高低血糖，降低高血糖；能兴奋呼吸；能增强和调节机体免疫功能，对干扰素系统有促进作用，可提高机体的抗病力；对流感病毒等多种病毒所致细胞病变有轻度抑制作用，对流感病毒感染小鼠有保护作用；有较广泛的抗菌作用；黄芪在细胞培养中，可使细胞数明显增多，细胞生长旺盛，寿命延长；能增强心肌收缩力，保护心血管系统，抗心率失常，扩张冠状动脉和外周血管，降低血压，能降低血小板粘附力，减少血栓形成；还有降血脂、抗衰老、抗缺氧、抗辐射、保肝等作用。
乳酸亚铁：本品为铁元素补充剂。铁为血红蛋白及肌红蛋白的主要组成成分。血红蛋白为红细胞中主要携氧者，肌红蛋白系肌肉细胞贮存氧的部位，为肌肉运动时提供氧的需要。与三羧循环有关的大多数酶和因子均含铁，或仅在铁存在时才发挥作用。机体缺乏铁，可引起休力不足等。
具体实施方式
实施例1 本发明胶囊剂的制备
银杏叶提取物30％、西洋参提取物40％、黄芪提取物25％、乳酸亚铁5％，余为辅料。
实施例2 本发明片剂的制备
银杏叶提取物40％、西洋参提取物30％、黄芪提取物28％、乳酸亚铁2％。将原料加入辅料适量，压片。
实施例3 本发明胶囊剂的制备
银杏叶提取物45％、西洋参提取物30％、黄芪提取物15％、乳酸亚铁10％，余为辅料。
Claims (2)
1.一种用于缓解体力疲劳的含有中药提取物的复方制剂，组成该制剂的活性成分及其重量含量是：银杏叶提取物30-45％、西洋参提取物30-40％、黄芪提取物15-28％、乳酸亚铁2-10％，余为辅料。
2.如权利要求1所述的一种含有中药提取物的复方制剂，其特征在于，银杏叶提取物含萜类内酯不少于5％；西洋参提取物总皂苷含量不少于5％；黄芪提取物含黄芪多糖不少于20％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210449016.1A CN103798771A (zh) | 2012-11-12 | 2012-11-12 | 一种含有中药提取物的复方制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210449016.1A CN103798771A (zh) | 2012-11-12 | 2012-11-12 | 一种含有中药提取物的复方制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103798771A true CN103798771A (zh) | 2014-05-21 |
Family
ID=50696542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210449016.1A Pending CN103798771A (zh) | 2012-11-12 | 2012-11-12 | 一种含有中药提取物的复方制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103798771A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1237445A (zh) * | 1999-05-26 | 1999-12-08 | 胡小波 | 银杏洋参钙胶囊 |
| CN1733035A (zh) * | 2005-08-16 | 2006-02-15 | 北京健科玉谷食品有限公司 | 一种抗疲劳保健品及制备方法 |
| JP2009179625A (ja) * | 2008-01-04 | 2009-08-13 | Kracie Seiyaku Kk | 抗ストレス・疲労防止、肌のキメ改善又はシワ改善・防止効果を有する組成物又は内服剤 |
| CN101703623A (zh) * | 2009-11-12 | 2010-05-12 | 西安斯强实业有限公司 | 一种具有缓解体力疲劳作用的胶囊剂 |
| CN102362881A (zh) * | 2011-10-31 | 2012-02-29 | 广西亿康药业股份有限公司 | 银杏洋参制剂的生产方法 |
-
2012
- 2012-11-12 CN CN201210449016.1A patent/CN103798771A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1237445A (zh) * | 1999-05-26 | 1999-12-08 | 胡小波 | 银杏洋参钙胶囊 |
| CN1733035A (zh) * | 2005-08-16 | 2006-02-15 | 北京健科玉谷食品有限公司 | 一种抗疲劳保健品及制备方法 |
| JP2009179625A (ja) * | 2008-01-04 | 2009-08-13 | Kracie Seiyaku Kk | 抗ストレス・疲労防止、肌のキメ改善又はシワ改善・防止効果を有する組成物又は内服剤 |
| CN101703623A (zh) * | 2009-11-12 | 2010-05-12 | 西安斯强实业有限公司 | 一种具有缓解体力疲劳作用的胶囊剂 |
| CN102362881A (zh) * | 2011-10-31 | 2012-02-29 | 广西亿康药业股份有限公司 | 银杏洋参制剂的生产方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101972353A (zh) | 一种用于防治心脑血管疾病的药物组合物 | |
| CN103766885A (zh) | 缓解体力疲劳的保健食品 | |
| CN102357208B (zh) | 一种治疗糖尿病、高血糖、高血压、高血脂的中药组合物 | |
| CN101810337A (zh) | 三七灵芝黄芪保健食品 | |
| CN103800407A (zh) | 一种保健品组合物 | |
| CN103564087A (zh) | 蛹虫草茶 | |
| CN103766888A (zh) | 一种含有西洋参提取物的制剂 | |
| CN102669340B (zh) | 一种改善营养性贫血的食品养血茶冲剂 | |
| CN101637490A (zh) | 降压解脂、保肝护心、防癌抗衰老的中药 | |
| CN108355055A (zh) | 一种用于治疗高血压的药物组合物 | |
| CN101406644A (zh) | 一种具有降血糖作用的药物 | |
| CN103349745A (zh) | 一种治疗糖尿病的中药汤剂 | |
| CN1686396A (zh) | 具有耐缺氧功能的保健品 | |
| CN103798755A (zh) | 一种用于抗疲劳的胶囊 | |
| CN103798771A (zh) | 一种含有中药提取物的复方制剂 | |
| CN102885313A (zh) | 一种抗疲劳的保健品 | |
| CN102151294A (zh) | 养心虫草酒 | |
| CN103800548A (zh) | 复方中药 | |
| CN103766887A (zh) | 含有黄芪提取物的制剂 | |
| CN103798758A (zh) | 一种含有银杏叶提取物的制剂 | |
| CN103768246A (zh) | 中药制剂 | |
| CN103766882A (zh) | 复方黄芪的制剂 | |
| CN103766881A (zh) | 一种中药保健食品 | |
| CN108079275A (zh) | 一种治疗高血压的养生中药组合物及其制备方法 | |
| CN103766884A (zh) | 一种新的复合制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C05 | Deemed withdrawal (patent law before 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140521 |